Table 3. Vector Expression in 2°CFU-S... | American Society of Hematology

Table 3.

Vector Expression in 2°CFU-S

Primary Recipient No.^3-150	MNDeGFPSN			LeGFPSN
Primary Recipient No.^3-150	Expression in 1° BM	Vector^3-151 (n)	Expression^3-152	Expression in 1° BM	Vector^3-151 (n)	Expression^3-152
1	60%	13/13	13/13	0.4%	13/15	0/13
(8 wks)		(3)			(4)
2	78.5%	6/6	6/6	ND	ND	ND
(6 mos)		(2)
3	65.1%	8/8	8/8	8.4%	8/12	0/8
(4 mos)		(3)			(3)
4	84.1%	11/11	11/11	4.4%	12/16	0/12
(6 mos)		(4)			(4)
5	40.5%	16/16	16/16	31%	13/13	0/13
(6 mos)		(4)			(4)

1-5		54/54	54/54		46/56	0/46
		100%	100%		82%	0%

Primary Recipient No.^3-150	MNDeGFPSN			LeGFPSN
Primary Recipient No.^3-150	Expression in 1° BM	Vector^3-151 (n)	Expression^3-152	Expression in 1° BM	Vector^3-151 (n)	Expression^3-152
1	60%	13/13	13/13	0.4%	13/15	0/13
(8 wks)		(3)			(4)
2	78.5%	6/6	6/6	ND	ND	ND
(6 mos)		(2)
3	65.1%	8/8	8/8	8.4%	8/12	0/8
(4 mos)		(3)			(3)
4	84.1%	11/11	11/11	4.4%	12/16	0/12
(6 mos)		(4)			(4)
5	40.5%	16/16	16/16	31%	13/13	0/13
(6 mos)		(4)			(4)

1-5		54/54	54/54		46/56	0/46
		100%	100%		82%	0%

Abbreviation: (n), number of secondary transplant recipients; ND, not done.

Time after 1° transplant when 2° transplant was performed.

Number of CFU-S PCR (+) for vector DNA/number of CFU-S tested.

Number of CFU-S (+) for eGFP expression by FACS/number of CFU-S tested.